When a doctor refers a patient to a specialist, they want that patient to receive quality care—and quickly. But messy documentation, lengthy clinical reviews and constant back and forth slows everything down. And the document work isn’t just data entry. It’s fine-tooth reasoning over dozens of pages of clinical information at a level of complexity that has largely stumped automation systems — and kept providers battling to cross their t’s and dot their i’s in an effort to see patients faster and get paid by insurance. Now, just a few months after announcing their Series A from a16z, Tennr is expediting millions of patients through the US healthcare system with an automation platform centered around their suite of document-reading machine learning models built specifically for medical documents.
Tennr's customers are cutting pre-visit patient processing periods from weeks to hours, while simultaneously reducing insurance claim denials for providers—a crucial advantage as healthcare reimbursements shrink and costs soar. The business has now secured $37 million in funding to grow their research team and expand their sales and marketing efforts to help more providers.
Tennr's $37 million Series B round was led by Lightspeed Ventures, with participation from existing investors a16z and Foundation Capital. This brings the company's total funding to over $61 million, following a Series A raise just six months ago. In the interim, Tennr has seen hockey-stick customer growth and achieved a series of technical breakthroughs with novel techniques to scaling vision-language models.
